| Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates |
Globe Newswire |
05/12 |
07:30 |
| BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients |
Globe Newswire |
05/12 |
07:30 |
| Vireo Growth Inc. Announces First Quarter 2026 Results |
Globe Newswire |
05/12 |
07:30 |
| Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates |
Globe Newswire |
05/12 |
07:30 |
| Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates |
Globe Newswire |
05/12 |
07:30 |
| Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference |
Globe Newswire |
05/12 |
07:30 |
| Compass Therapeutics to Participate in Upcoming May Investor Events |
Globe Newswire |
05/12 |
07:30 |
| Harvard Bioscience Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
07:30 |
| SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights |
Globe Newswire |
05/12 |
07:30 |
| BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1 |
Globe Newswire |
05/12 |
07:30 |
| Nayax Reports First Quarter 2026 Results |
Globe Newswire |
05/12 |
07:30 |
| No Deposit Bonus Casinos for Real Money- BitStarz Unveils Major 2026 Update Featuring Free Spins, Fast Withdrawals & Slots |
Globe Newswire |
05/12 |
07:22 |
| POET Technologies Announces Appointment of Sandeep Kumar as Chief Operating Officer |
Globe Newswire |
05/12 |
07:22 |
| Hub Group Files Form 12b-25 and Provides First Quarter 2026 Business Update |
Globe Newswire |
05/12 |
07:20 |
| Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/12 |
07:05 |
| Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma |
Globe Newswire |
05/12 |
07:05 |
| Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/12 |
07:05 |
| NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth |
Globe Newswire |
05/12 |
07:05 |
| Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/12 |
07:01 |
| Legend Biotech Reports First Quarter 2026 Results and Recent Highlights |
Globe Newswire |
05/12 |
07:00 |
| Abaxx Announces First Quarter 2026 Earnings and Business Update Call |
Globe Newswire |
05/12 |
07:00 |
| Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant) |
Globe Newswire |
05/12 |
07:00 |
| Yukon Metals Expands Porphyry Portfolio With New Northern BC Property Near Yukon Border |
Globe Newswire |
05/12 |
07:00 |
| Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights |
Globe Newswire |
05/12 |
07:00 |
| Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update |
Globe Newswire |
05/12 |
07:00 |
